MedPath

A clinical trial to study the effects of two drugs, Eladi churna and yastimadhu churna in patients with Amlapitta.

Not Applicable
Conditions
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Registration Number
CTRI/2021/05/033554
Lead Sponsor
Gurukul Campus UAU haridwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having classical symptoms of Amlapitta.

Patients of either sex.

Chronicity upto 5 years.

patients between the age group 16-60 years.

Exclusion Criteria

Patients below 16 years and above 60 years.

Chronicity more than 5 years.

Patients having organic disease like gastric ulcer, duodenal ulcer.

Patients suffering from Amlapitta with any chronic disease like-Hiatus Hernia; Asthma, Tuberculosis, Malignancies, Liver Cirrhosis and Chronic Renal Failure, Diabetes etc. exclude from the study.

Any other systemic disorder other than Amlapitta.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in subjective parameters like-â?¢Hruddkanthadaha â?? Burning in chest and throat <br/ ><br>â?¢Tiktamlodgara â??Acid eructation <br/ ><br>â?¢Avipaka â??Indigesion <br/ ><br>â?¢Aruchiâ?? Anorexia <br/ ><br>â?¢Utkleshâ?? Nausea <br/ ><br>â?¢Gauravâ??Heaviness in whole body <br/ ><br>â?¢Shirashoolâ?? Headache <br/ ><br>â?¢Hritshoolâ??chest pain <br/ ><br>Timepoint: For subjective parameters at-1st,15th,30th,45th days
Secondary Outcome Measures
NameTimeMethod
Relief in objective parameters like <br/ ><br>â?¢Hb%,TLC,DLC,ESR <br/ ><br>â?¢Blood sugar: RBS <br/ ><br>â?¢Fractional Meal Test <br/ ><br>Timepoint: For objective parameters- <br/ ><br>1 and 45 days
© Copyright 2025. All Rights Reserved by MedPath